Large-scale testing (Phase 3)Study completedNCT04294667
What this trial is testing
Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Who this might be right for
Systemic Lupus Erythematosus
UCB Biopharma SRL 321